Is There A Role for Abscisic Acid, A Proven Anti-Inflammatory Agent, in the Treatment of Ischemic Retinopathies?
View/ Open
Impact
Scholar |
Other documents of the author: Baliño, Pablo; Gomez-Cadenas, Aurelio; López Malo, Daniel; Romero, Francisco J.; Muriach, Maria
Metadata
Show full item recordcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/2508
comunitat-uji-handle3:10234/6999
comunitat-uji-handle4:
INVESTIGACIONMetadata
Title
Is There A Role for Abscisic Acid, A Proven Anti-Inflammatory Agent, in the Treatment of Ischemic Retinopathies?Author (s)
Date
2019Publisher
MDPIISSN
2076-3921Bibliographic citation
BALIÑO, Pablo, et al. Is There A Role for Abscisic Acid, A Proven Anti-Inflammatory Agent, in the Treatment of Ischemic Retinopathies?. Antioxidants, 2019, vol. 8, no 4, p. 104Type
info:eu-repo/semantics/articlePublisher version
https://www.mdpi.com/2076-3921/8/4/104Version
info:eu-repo/semantics/publishedVersionSubject
Abstract
Ischemic retinopathies (IRs) are the main cause of severe visual impairment and sight loss, and are characterized by loss of blood vessels, accompanied by hypoxia, and neovascularization. Actual therapies, based on ... [+]
Ischemic retinopathies (IRs) are the main cause of severe visual impairment and sight loss, and are characterized by loss of blood vessels, accompanied by hypoxia, and neovascularization. Actual therapies, based on anti-vascular endothelial growth factor (VEGF) strategies, antioxidants or anti-inflammatory therapies are only partially effective or show some adverse side effects. Abscisic acid (ABA) is a phytohormone present in vegetables and fruits that can be naturally supplied by the dietary intake and has been previously studied for its benefits to human health. It has been demonstrated that ABA plays a key role in glucose metabolism, inflammation, memory and tumor growth. This review focuses on a novel and promising role of ABA as a potential modulator of angiogenesis, oxidative status and inflammatory processes in the retina, which are the most predominant characteristics of the IRs. Thus, this nutraceutical compound might shed some light in new therapeutic strategies focused in the prevention or amelioration of IRs-derived pathologies. [-]
Is part of
Antioxidants, 2019, vol. 8, no 4Investigation project
Generalitat Valenciana: Prometeo 94/2016; Universitat Jaume I: UJI-A2016-03Rights
info:eu-repo/semantics/openAccess
This item appears in the folowing collection(s)
- MED_Articles [645]
- CAMN_Articles [566]
The following license files are associated with this item: